Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 19 Jan 2024 for Clearside Biomedical, Inc., €15k. Read the official filing
Filing timeline
BuySaleCharles A. Deignan
Insider track record
Disclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Charles A. Deignan: trading record in brief
All filings by Charles A. Deignan on record concern Clearside Biomedical, Inc., in the capacity of finance chief. Between 21 June 2021 and 19 January 2024, the trades on record add up to 8 filings.
No open-market purchase appears, only 4 sales worth €61k. The rest of the record consists of 2 share grants and 2 option exercises. 2024 to date brings no purchases and 1 sale.
On 19 January 2024 came the latest disclosure, an open-market sale for €15k in Clearside Biomedical, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Charles A. Deignan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
12,900 shares@ US$1.2814.0% of flowCommon StockSEC:0001209191-24-001959:0
34,090 shares@ US$0.4011.7% of flowCommon StockSEC:0001209191-23-049346:0
14,030 shares@ US$1.5018.0% of flowCommon StockSEC:0001209191-23-004258:0
23,636 shares@ US$0.408.2% of flowCommon StockSEC:0001209191-22-062169:0
46,250 shares0Common StockSEC:0001209191-22-005437:0
43,750 shares0Common StockSEC:0001209191-22-004194:0
2,800 shares@ US$6.4118.6% of flowCommon StockSEC:0001209191-21-057457:0
2,938 shares@ US$4.3713.1% of flowCommon StockSEC:0001209191-21-042803:0
8 of 8 declarations
